2018 HEPATOBILIARY AND PANCREATIC CANCER CONFERENCE - cmetracker.net
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2018 HEPATOBILIARY
AND PANCREATIC
CANCER CONFERENCE
APRIL 27 - 28, 2018 | Honolulu, Hawai‘i
The Sullivan Conference Center at the
University of Hawai‘i Cancer Center
QMC-Stacked Flushed Left
Black
PMS 293C
FEATURED SPEAKERS
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center
Robert Lewandowski, MD PMS 293U
Northwestern University, Feinberg School of Medicine
Claudius Conrad, MD, PhD
MD Anderson Cancer Center
CMYK (91,71,1,0)
2018 HEPATOBILIARY AND PANCREATIC CANCER CONFERENCE April 27-28, 2018 | Honolulu, Hawai‘i The Sullivan Conference Center at the University of Hawai‘i Cancer Center PURPOSE: To bring together experts from around the world for an in-depth look at treating and understanding hepatopancreaticobiliary (HPB) cancers (liver, pancreas, gall bladder, ampullary, and bile duct cancers). This conference will provide a venue for researchers and clinicians to learn about current research and up-to-date treatments. SIGNIFICANCE: Risk factors for hepatocellular cancer (HCC) include viral hepatitis B, C, alcohol consumption, and nonalcoholic fatty liver disease. The high rates of viral hepatitis infections in Asian and Pacific Islander populations have resulted in Hawai‘i having the second highest incidence of primary liver cancer in the nation (Hawai‘i Cancer at a Glance, 2009-2013, pub. Dec 2016). In addition, Hawai‘i has a high incidence of bile duct cancer. These cancers are often found with advanced disease and 5 year survival from these cancers is less than 20%. Pancreatic cancer incidence in Hawai‘i remains significantly higher than in the U.S. overall. Hawai‘i ranks 6th among U.S. states for incidence of pancreatic cancer. The 5 year survival rate for those diagnosed with pancreatic cancer is 7.7% (SEER 18 2006-2012). Because Hawai‘i has a disproportionate amount of hepatobiliary/pancreas cancers, active research is underway to investigate this. This conference will serve both to highlight the research done locally and to exchange ideas with national and international experts. OVERVIEW: Friday, April 27 will be dedicated to presentations by University of Hawai‘i-affiliated and visiting researchers on current basic and translational research efforts involving genomics, proteomics, tumor immunology, and tumor angiogenesis. Saturday, April 28 will be dedicated to presentations by community and visiting clinicians on the current methods for diagnosis, detection, and treatments of HPB and Pancreatic cancers including resection, ablation, and systemic therapies. ATTENDEES: Approximately 100 physicians and researchers from Hawai‘i, the Asia-Pacific region, and the contiguous United States will attend. Speaker invitations will be extended to NIH and top national and international hospitals and research institutes.
PROGRAM • Friday, April 27, 2018
7:30 am Registration & Breakfast
8:00 am Welcome & Opening Remarks
Randall Holcombe, MD
Director, University of Hawaii Cancer Center
SESSION I Moderator: TBD
8:05 am Genomic Analysis of Cholangiocarcinoma
Mitesh Borad, MD
Mayo Clinic Cancer Center, Scottsdale, AZ
8:50 am mRNA’s in Hepatic Cancer Stem Cell Heterogeneity
Junfang Ji, PhD
University of Hawaii Cancer Center, Honolulu, HI
Professor, Life Sciences Institute
Zhejiang University, Hangzhou, Zhejiang, China
9:35 am New Agents in Treatment of HCC
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center
New York, NY
10:20 am Break
SESSION II Moderator: TBD
10:35 am DNA Methylation in Hepatocellular Carcinoma
Min-Ae Song, PhD
The Ohio State University, College of Public Health
Columbus, OH
11:20 am Bile Acid – Microbiota Cross-talk and its Effect
on Liver Cancer
Wei Jia, PhD
University of Hawaii Cancer Center, Honolulu, HI
11:45 am Imaging Lipid Metabolism in Liver Cancer
Sandi Kwee, MD, PhD
University of Hawaii Cancer Center, Honolulu, HI
Poster Abstract Submission Requirements
for 2018 HPB and Pancreatic Cancer Conference, Honolulu, Hawaii
Deadline for submission has been extended to: March 23, 2018
· Organize the abstract according to four sections, identified by the following headers:
Background, Methods, Results, and Conclusions.
· Do not use proprietary names in the title or body of the abstract. If necessary, you may
include the proprietary name in parentheses directly after the generic name on first use
in the body of the abstract.
· Do not refer to study results or conclusions in the title of the abstract. The title should
objectively describe the study.
· You may include one data table with the abstract. Do not include illustrations or graphics.
· Do not exceed 2,000 characters (approximately 300-350 words), not including spaces,
for the total of your abstract title, body, and table.
· Individuals may serve as first author of more than one abstract.
Send poster abstracts to HPBabstracts2018@cc.hawaii.eduPROGRAM • Saturday, April 28, 2018
8:00 am Registration & Breakfast
SESSION III Pancreas Moderator: Jared Acoba, MD
8:30 am Pancreatic Neuroendocrine Tumors
Larissa Fujii-Lau, MD
The Queen’s Medical Center, Honolulu, HI
8:55 am Surgical Treatment of Pancreatic Cancer
Claudius Conrad, MD, PhD
MD Anderson Cancer Center, Houston TX
9:40 am Chemotherapy Treatment for Pancreatic Cancer
Mitesh Borad, MD
Mayo Clinic Cancer Center, Scottsdale, AZ
10:25 am Break
SESSION IV Cholangiocarcinoma Moderator: Jared Acoba, MD
10:40 am Endoscopic Approaches to Inoperable
Cholaniocarcinoma
Aaron Small, MD
Pali Momi Medical Center / Hawaii
Gastroenterology Specialists, Honolulu, HI
11:05 am Precision Medicine and Immunotherapy Advances in
Biliary Cancers
Thomas DeLeon, MD
Mayo Clinic Cancer Center, Scottsdale, AZ
11:50 am Percutaneous Diagnosis/Management
of Cholangiocarcinoma
Anthony Herriera, MD
Radiology Associates of Hawaii, Honolulu, HI
12:15 am Lunch
The Dr. Noguchi Story
SESSION V Liver Moderator: Linda Wong, MD
1:15 pm Risk Factors of Hepatocellular Carcinoma in the U.S.
Herbert Yu, MD, PhD
University of Hawaii Cancer Center, Honolulu, HI
1:40 pm Radioembolization-Advances in Treating
Hepatocellular Carcinoma
Robert Lewandowski, MD, Professor of Radiology
Northwestern University, Feinber School of Medicine,
Chicago, IL
2:25 pm Microwave/RF Ablation
Louis Hinshaw, MD
Professor of Radiology, University of Wisconsin,
School of Medicine and Public Health, Madison, WI
3:15 pm Stereotactic Body Radiation Therapy for Liver Tumors
Gene-Fu Liu, MD
The Queen’s Medical Center, Honolulu, HI2018 HEPATOBILIARY April 27-28, 2018
Sullivan Conference Center at the
AND PANCREATIC University of Hawai‘i Cancer Center
CANCER CONFERENCE 651 Ilalo St / Honolulu, HI 96813
Conference Schedule
Friday, April 27, 2018
7:30 AM – 8:00 AM: Registration & Continental Breakfast
8:00 AM – 12:10 PM: Sessions
Saturday, April 28, 2018
8:00 AM – 8:30 AM: Registration & Continental Breakfast
8:30 AM – 3:40 PM: Sessions (lunch will be provided)
Registration Form
Name: ____________________________________________________________
Last First
Title: ______________________________________________________________
Affiliation: __________________________________________________________
Mailing Address: ____________________________________________________
__________________________________________________________________
Phone: _____________________ Email: ________________________________
Registration Fee
Early registration Regular registration
by March 16, 2018 March 17 - April 13
Two-day conference $100.00 $150.00
The Hawai‘i Consortium for Continuing Medical Education designations this live ac-
tivity for a maximum of 9.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim
only the credits commensurate with the extent of their participation in the activity.
Accepted Forms of Payment
CHECKS: Make check payable to: UNIVERSITY OF HAWAII
Mail to: University of Hawaii Conference & Event Services
2465 Campus Road, Rm 121G / Honolulu, HI 96822
CREDIT CARD: VISA, MasterCard, Discover, JCB or Diner’s Club is
required during the online registration process. Your registration
will be invalid without the payment information.
https://www.uhbooks.hawaii.edu/conference/hpb2018.asp
PURCHASE ORDER: Government-issued purchase order is
accepted with original signature
CANCELLATION POLICY: If you need to cancel your registration, please send a
written notice to the University of Hawaii Conference & Event Services. A full refund
will be processed if notification is received by April 13, 2018. No refunds will be made
after April 13, 2017. Email your notice of cancellation to pauljd@hawaii.eduAccessibility Assistance
If you require assistance with mobility, hearing, or visual access, please
contact UH Conference & Event Services at 808.956.8204 or pauljd@
hawaii.edu by April 13, 2018.
QMC-Stacked Flushed Left
Black
PMS 293C
PMS 293U
CMYK (91,71,1,0)
CONFERENCE CONTENT & REGISTRATION INQUIRIES
LOGISTICS RELATED INQUIRIES • Paul J. Donnelly
• Darlene Sardinha University of Hawai‘i at Ma-noa
dsardinha@queens.org Conference & Event Services
Ph: 808-691-8984 2465 Campus Road, Rm 121 G
White
• Kate Bryant-Greenwood Ph: 808-956-8204
Kbryantgreenwood@cc.hawaii.edu pauljd@hawaii.edu
Ph: 808-441-7715
• For more information visit:
http://www.uhcancercenter.org
The Queen’s Cancer Center brings the people of Hawai‘i a comprehensive cancer treatment and research center with
a mission to provide superior cancer care. As Hawai‘i’s premier cancer treatment facility, it ranks among the best of
its kind in the nation. Aggressively treating all types of cancer, the Queen’s Cancer Center offers advanced technology
combined with patient-centered, multidisciplinary care in a comfortable place of healing. The Queen’s Cancer Center
strives to ensure that treatment and cancer care coordination is as convenient and stress-free as possible. Virtually
every aspect of cancer diagnosis, treatment planning, and treatment is physically brought together in one place,
minimizing the need for patients and their caregivers to travel to different providers, or to travel to the mainland for
services. The Queen’s Cancer Center pledge is to put patients first by focusing on each individual’s needs and offering
a full array of expert services to promote healing at all levels.You can also read
